Champions ONCOLOGY, Inc. (CSBR) intrinsic value & 10-year financials
Champions ONCOLOGY, Inc. (CSBR) has a Graham intrinsic value of $10.96 per share. At $4.70 on Oct 17, 2026, the stock trades 57% below that value. Over the last 10 fiscal years revenue grew 16.2% a year to $59.4M, with an average return on invested capital of -91.9%.
- Graham intrinsic value
- $10.96
- Share price (Oct 17, 2026)
- $4.70
- Price vs Graham value
- 57% below
- Market cap
- $65.0M
- Revenue (FY2026)
- $59.4M
- Revenue growth (10-yr CAGR)
- 16.2%
- ROIC (10-yr avg)
- -91.9%
- Free cash flow (FY2026)
- -$5.0M
CSBR 10-year financial history
| Fiscal year | Revenue | Net income | EPS (diluted) | Free cash flow | Operating margin | ROIC |
|---|---|---|---|---|---|---|
| FY2026 | $59.4M | -$1.2M | -$0.08 | -$5.0M | -1.9% | -295.3% |
| FY2025 | $56.9M | $4.7M | $0.33 | $7.0M | 8.0% | 1828.5% |
| FY2024 | $50.2M | -$7.3M | -$0.54 | -$7.0M | -14.7% | -395.8% |
| FY2023 | $53.9M | -$5.3M | -$0.39 | $1.1M | -9.8% | -101.0% |
| FY2022 | $49.1M | $548.0K | $0.04 | $4.1M | 1.2% | 5.7% |
| FY2021 | $41.0M | $362.0K | $0.02 | -$5.0M | 0.9% | 5.2% |
| FY2020 | $32.1M | -$2.0M | -$0.17 | $685.0K | -5.6% | 422.7% |
| FY2019 | $27.1M | $128.0K | $0.01 | $1.0M | 1.0% | -15.0% |
| FY2018 | $20.2M | -$1.5M | -$0.13 | -$2.5M | -6.7% | -672.0% |
| FY2017 | $15.4M | -$6.9M | — | -$3.6M | -44.2% | -1702.2% |
Source: annual 10-K filings on SEC EDGAR. Figures in USD.
Executive summary
CHAMPIONS ONCOLOGY, INC. is a consistent compounder, expanding top-line revenue at 16.2% annually over the past decade.
CHAMPIONS ONCOLOGY, INC. has historically struggled to out-earn its cost of capital, averaging just -11.2% ROIC.
CHAMPIONS ONCOLOGY, INC. capital allocation metrics are N/A for the decade; share count and net debt history are incomplete.
Benjamin Graham lens
Under Benjamin Graham's formula using SEC EDGAR fundamentals, CHAMPIONS ONCOLOGY, INC. is modeled at 15.0% normalized earnings growth with a 5.1% bond-yield adjustment. The resulting Graham intrinsic value estimate is $10.96 per share.